https://charts.traderzeitung.de/phases/US63909J1088 string(1405) "{"isin":"US63909J1088","name":"Nautilus Biotechnology Inc","stock_id_xnas":22185043,"stock_id_xnys":null,"generated_at":"2026-09-24 01:37:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.955,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.994,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":4.0838},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.958,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-3.6217},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"

Nautilus Biotechnolgy Aktie News & Nachrichten

[WKN: A3CSCD | Symbol: NAUT]

Realtimekurs

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Nautilus Biotechnolgy gefunden werden.

Nautilus Biotechnolgy Nachrichtenticker öffnen

MT Newswires 11.09.2026 22:34 Uhr

Nautilus Biotechnology reicht Regalregistrierung über 300 Millionen US-Dollar ein

04:33 PM EDT, 09/11/2026 (MT Newswires) -- Nautilus Biotechnology (NAUT) hat am Freitag bei der US-Börsenaufsichtsbehörde SEC eine Registrierungserklä

MT Newswires 09.09.2026 13:46 Uhr

Artikel aus der Redaktion der Trader-Zeitung

Nautilus Biotechnology reicht Regalregistrierung über 300 Millionen US-Dollar ein

--Leerink Partners nimmt die Beobachtung von Nautilus Biotechnolgy mit einer Outperform-Bewertung und einem Kursziel von 4 $ auf